A phase I/II multicentric trial of gemcitabine and epirubicin in patients with advanced pancreatic carcinoma
✍ Scribed by Eickhoff, A; Martin, W; Hartmann, D; Eickhoff, J C; Möhler, M; Galle, P R; Riemann, J F; Jakobs, R
- Book ID
- 109998844
- Publisher
- Nature Publishing Group
- Year
- 2006
- Tongue
- English
- Weight
- 73 KB
- Volume
- 94
- Category
- Article
- ISSN
- 0007-0920
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract ## BACKGROUND There is no effective systemic therapy for patients with hepatocellular carcinoma. A recent trial reported a moderate antitumor activity for gemcitabine among Asian patients with advanced hepatocellular carcinoma. This led to our examination of the efficacy and tolerabili
## BACKGROUND. Anthracyclines are among the most active drugs in the treatment of breast carcinoma and exhibit a steep dose-response curve in vitro. This trial was performed to determine the efficacy and toxicity of epirubicin in the treatment of patients with advanced breast carcinoma when adminis